Signal Transduction and Targeted Therapy · 2023 · 24 citations · 33 references
Life SciencesImmunologyMolecular BiologyAutoimmunityImmunoregulationSignal TransductionAutoimmune InflammationCytokine BiologyHelper T Cell SubsetsInflammatory Cell ResponsesInflammatory Response RegulationInflammatory SignalingCd4 Positive T CellsCellular BioenergeticsEukaryotic Elongation FactorsInflammatory Cytokine ProductionInflammatory Microenvironment ModulationInterleukin-17 PathwayMetabolic Regulation Of InflammationPro-inflammatory Cytokine Expression
Abstract CD4 + T cells, particularly IL-17-secreting helper CD4 + T cells, play a central role in the inflammatory processes underlying autoimmune disorders. Eukaryotic Elongation Factor 2 Kinase (eEF2K) is pivotal in CD8 + T cells and has important implications in vascular dysfunction and inflammation-related diseases such as hypertension. However, its specific immunological role in CD4 + T cell activities and related inflammatory diseases remains elusive. Our investigation has uncovered that the deficiency of eEF2K disrupts the survival and proliferation of CD4 + T cells, impairs their ability to secrete cytokines. Notably, this dysregulation leads to heightened production of pro-inflammatory cytokine IL-17, fosters a pro-inflammatory microenvironment in the absence of eEF2K in CD4 + T cells. Furthermore, the absence of eEF2K in CD4 + T cells is linked to increased metabolic activity and mitochondrial bioenergetics. We have shown that eEF2K regulates mitochondrial function and CD4 + T cell activity through the upregulation of the transcription factor, signal transducer and activator of transcription 3 (STAT3). Crucially, the deficiency of eEF2K exacerbates the severity of inflammation-related diseases, including rheumatoid arthritis, multiple sclerosis, and ulcerative colitis. Strikingly, the use of C188-9, a small molecule targeting STAT3, mitigates colitis in a murine immunodeficiency model receiving eEF2K knockout (KO) CD4 + T cells. These findings emphasize the pivotal role of eEF2K in controlling the function and metabolism of CD4 + T cells and its indispensable involvement in inflammation-related diseases. Manipulating eEF2K represents a promising avenue for novel therapeutic approaches in the treatment of inflammation-related disorders.
33
Posttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis
Chih‐Hao Chang, Jonathan D. Curtis, Leonard B. Maggi et al. · Cell · 2013 · 2.2K citations · Full text
m6A mRNA methylation controls T cell homeostasis by targeting the IL-7/STAT5/SOCS pathways
Huabing Li, Jiyu Tong, Shu Zhu et al. · Nature · 2017 · 1.1K citations · Full text